Arkolith/Insider Trading/SGRY/Form 4

Brittenham Marissa

Chief Strategy OfficerSurgery Partners, Inc. (SGRY) · full profile →Form 4 · filed Mar 9, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$120K
Net Open-Market Flow
-$120K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 6, 2026Sell(S)9K$13.70$120K55K
Mar 5, 2026Grant(A)18K$14.11$250K72K
Mar 5, 2026Grant(A)16K$14.11$231K89K
Mar 5, 2026Grant(A)9K$14.11$129K98K

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001638833-26-000019) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML